Page last updated: 2024-09-03

3-(2,2,2-trimethylhydrazine)propionate and Chronic Disease

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Chronic Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's4 (40.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fabritskaya, SV; Shilina, NN; Statsenko, S; Turkin, SV1
Gerasimenko, MIu; P'ianzina, AV1
Paleev, FN; Paleev, NR1
Chumburidze, V; Kikalishvili, T; Sulashvili, T1
Iushchuk, EN; Khadzegova, AB; Sadulaeva, IA; Shkol'nik, EL; Vakhromeeva, MN; Vasiuk, IuA; Vit'ko, NK1
Belenkova, SV; Shilina, NN; Sporova, OE; Statsenko, ME1
Kutuzova, AE; Nedoshivin, AO; Perepech, NB; Petrova, NN1
Artiukh, VP; Sakharchuk, II; Sisetskiĭ, AP; Starodub, NF1
Agranovskiĭ, VB; Berenbeĭn, BA; Glozman, VN; Kirmane, RE; Pervushina, NV; Shur, AA1
Elagina, LV; Orlov, VA; Sokolova, VI; Zamotaev, IP; Zavolovskaia, LI1

Trials

4 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Chronic Disease

ArticleYear
[Microcirculatory effects of fluctophoresis series in patient with moderate chronic periodontal disease].
    Stomatologiia, 2013, Volume: 92, Issue:4

    Topics: Adult; Aged; Blood Vessels; Chronic Disease; Electrophoresis; Female; Galantamine; Heme; Humans; Laser-Doppler Flowmetry; Male; Methylhydrazines; Microcirculation; Middle Aged; Periodontal Diseases; Periodontium

2013
[Definition of therapeutic effect of mildronate in patients with chronic heart failure].
    Georgian medical news, 2005, Issue:122

    Topics: Cardiac Output, Low; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; Methylhydrazines; Treatment Outcome

2005
[Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Diuretics; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Methylhydrazines; Middle Aged; Positron-Emission Tomography; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left

2007
[The use of mildronate in combined therapy of postinfarction chronic heart failure in patients with type 2 diabetes mellitus].
    Klinicheskaia meditsina, 2007, Volume: 85, Issue:7

    Topics: Cardiovascular Agents; Chronic Disease; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Infarction; Prospective Studies

2007

Other Studies

6 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Chronic Disease

ArticleYear
[Efficacy of Short-Term Therapy With Meldonium in Patients With Chronic Heart Failure of Ischemic Etiology and Type 2 Diabetes Mellitus].
    Kardiologiia, 2017, Volume: 57, Issue:4

    Topics: Aged; Cardiovascular Agents; Chronic Disease; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Ischemia

2017
[Achievements in the diagnosis and treatment of immune myocarditis].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2003, Issue:12

    Topics: Acute Disease; Adjuvants, Immunologic; Autoantibodies; Autoantigens; Autoimmune Diseases; B-Lymphocytes; Cardiovascular Agents; Chronic Disease; DNA; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Methylhydrazines; Myocarditis; Myocardium; Recurrence; T-Lymphocytes; Virus Diseases

2003
[Effect of mildronate on life quality of patients with chronic heart failure].
    Terapevticheskii arkhiv, 1999, Volume: 71, Issue:8

    Topics: Administration, Oral; Adult; Cardiovascular Agents; Chronic Disease; Female; Heart Failure; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Ischemia; Patient Satisfaction; Quality of Life; Stroke Volume; Treatment Outcome

1999
[Erythrocyte functional activity in patients with heart failure and the possible means for its correction].
    Terapevticheskii arkhiv, 1992, Volume: 64, Issue:9

    Topics: Adult; Aged; Cardiovascular Agents; Chronic Disease; Drug Therapy, Combination; Erythrocytes; Heart Failure; Hemodynamics; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Ischemia

1992
[Use of mildronate in therapy of seroresistant syphilis (serologic and immunologic comparisons].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1991, Volume: 36, Issue:5

    Topics: Adult; Chronic Disease; Female; Humans; Lymphocytes; Male; Methylhydrazines; Middle Aged; Syphilis; Syphilis Serodiagnosis

1991
[Clinico-immunologic aspects of using mildronate in patients with bronchopulmonary diseases].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1990, Volume: 35, Issue:7

    Topics: Adjuvants, Immunologic; Asthma; Bronchi; Bronchitis; Bronchodilator Agents; Chronic Disease; Humans; Immune Complex Diseases; Immune Tolerance; Methylhydrazines

1990